Kevin Hodgetts (29 results)

paperback. Condition: Very Good. Shipped within 24 hours from our UK warehouse. Clean, undamaged book with no damage to pages and minimal wear to the cover. Spine still tight, in very good condition. Remember if you are not happy, you are covered by our 100% money back guarantee.

384 pp.; 24.9 x 30.7 cm.; sewn bound; black-and-white & color; edition size unknown; unsigned and unnumbered; offset-printed Exhibition catalogue published in conjunction with show held at the Museum of Contemporary Art, Los Angeles, October 17, 1989 - February 18, 1990. Introduction by Richard Koshalek, with written contributions by Elizabeth A.T. Smith, Esther McCoy, Amelia Jones, Thomas S. Hines, Helen Searing, Kevin Starr, Reyner Banham, and Dolores Hayden. Architects and designers in the catalogue include Adèle Naudé Santos, Craig Hodgetts, Ming Fung, Eric Owen Moss, Itsuko Hasegawa, Toyo Ito, Robert Mangurian, Charles Eames, Craig Ellwood, A. Quincy Jones, Pierre Koenig, Richard Neutra, and Raphael Soriano. Includes biographies, chronology, bibliography, and index. Printed in color and black-and-white. New. As issued in publisher's shrink-wrap. Due to size and weight additional shipping charges will be required for international orders.…

HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.

hardcover. Condition: New. Brand new book, sourced directly from publisher. Dispatch time is 9-10 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New.

Hardback. Condition: New. 1st. Provides insights into the drug discovery innovations that are shaping future CNS therapies In the vast field of neuroscience, drug discovery targeting the central nervous system (CNS) presents both extraordinary opportunities and complex challenges. Disorders such as Alzheimer's disease, schizophrenia, and epilepsy affect millions worldwide, demanding innovative therapeutic strategies. Yet understanding brain processes and overcoming the blood-brain barrier continue to pose significant hurdles for researchers and developers alike. Trends in CNS Drug Discovery offers a comprehensive overview of the methodologies, successes, and challenges shaping this critical area of pharmaceutical research. Covering a wide range of key areas, from current therapeutic paradigms to emerging technologies, this state-of-the-art volume brings together expertise from leading scientists and drug developers who address the role of cannabinoids and psychedelics in advancing CNS therapeutics, discuss emerging modalities such as protein degraders and allosteric modulators, examine funding strategies and academic-industrial collaborations, highlight advancements in brain-penetrating cancer treatments and other high-impact areas, and more. Explores cutting-edge methodologies, including biomarkers, animal models, and brain imaging for CNS drug discoveryReviews innovative therapies such as combination drugs and prodrugs for improved treatment outcomesAnalyzes challenges in targeting diseases including Alzheimer's and schizophrenia with novel therapeutic strategiesIncludes real-world case studies demonstrating achievements and lessons in CNS drug development A critical reference for academic researchers and industry professionals in medicinal chemistry, pharmaceutical research, and neurobiology, Trends in CNS Drug Discovery is also an ideal resource for graduate-level courses in neuroscience or pharmaceutical sciences.…

Condition: New.

Condition: New. In English.

Buch. Condition: Neu. Neuware -Trends and challenges in one of the largest areas of contemporary drug development - presented by industry professionals with a track record of discovering new drugs and treatments. 480 pp. Englisch.

Buch. Condition: Neu. Neuware -Trends and challenges in one of the largest areas of contemporary drug development - presented by industry professionals with a track record of discovering new drugs and treatments. 480 pp. Englisch.

Buch. Condition: Neu. Neuware -Provides insights into the drug discovery innovations that are shaping future CNS therapies.

Condition: New. 1st edition NO-PA16APR2015-KAP.

Condition: New.

Hardback. Condition: New. 1st. Provides insights into the drug discovery innovations that are shaping future CNS therapies In the vast field of neuroscience, drug discovery targeting the central nervous system (CNS) presents both extraordinary opportunities and complex challenges. Disorders such as Alzheimer's disease, schizophrenia, and epilepsy affect millions worldwide, demanding innovative therapeutic strategies. Yet understanding brain processes and overcoming the blood-brain barrier continue to pose significant hurdles for researchers and developers alike. Trends in CNS Drug Discovery offers a comprehensive overview of the methodologies, successes, and challenges shaping this critical area of pharmaceutical research. Covering a wide range of key areas, from current therapeutic paradigms to emerging technologies, this state-of-the-art volume brings together expertise from leading scientists and drug developers who address the role of cannabinoids and psychedelics in advancing CNS therapeutics, discuss emerging modalities such as protein degraders and allosteric modulators, examine funding strategies and academic-industrial collaborations, highlight advancements in brain-penetrating cancer treatments and other high-impact areas, and more. Explores cutting-edge methodologies, including biomarkers, animal models, and brain imaging for CNS drug discoveryReviews innovative therapies such as combination drugs and prodrugs for improved treatment outcomesAnalyzes challenges in targeting diseases including Alzheimer's and schizophrenia with novel therapeutic strategiesIncludes real-world case studies demonstrating achievements and lessons in CNS drug development A critical reference for academic researchers and industry professionals in medicinal chemistry, pharmaceutical research, and neurobiology, Trends in CNS Drug Discovery is also an ideal resource for graduate-level courses in neuroscience or pharmaceutical sciences.…

Buch. Condition: Neu. Trends in CNS Drug Discovery | Dario Doller (u. a.) | Buch | Trends in Drug Discovery | 480 S. | Englisch | 2026 | Wiley-VCH GmbH | EAN 9783527352807 | Verantwortliche Person für die EU: Wiley-VCH GmbH, Boschstr. 12, 69469 Weinheim, product-safety[at]wiley[dot]com | Anbieter: preigu. …

hardcover. Condition: New.

Condition: Hervorragend. Zustand: Hervorragend | Seiten: 480 | Sprache: Englisch | Produktart: Bücher | Provides insights into the drug discovery innovations that are shaping future CNS therapies In the vast field of neuroscience, drug discovery targeting the central nervous system (CNS) presents both extraordinary opportunities and complex challenges. Disorders such as Alzheimer's disease, schizophrenia, and epilepsy affect millions worldwide, demanding innovative therapeutic strategies. Yet understanding brain processes and overcoming the blood-brain barrier continue to pose significant hurdles for researchers and developers alike. Trends in CNS Drug Discovery offers a comprehensive overview of the methodologies, successes, and challenges shaping this critical area of pharmaceutical research. Covering a wide range of key areas, from current therapeutic paradigms to emerging technologies, this state-of-the-art volume brings together expertise from leading scientists and drug developers who address the role of cannabinoids and psychedelics in advancing CNS therapeutics, discuss emerging modalities such as protein degraders and allosteric modulators, examine funding strategies and academic-industrial collaborations, highlight advancements in brain-penetrating cancer treatments and other high-impact areas, and more. - Explores cutting-edge methodologies, including biomarkers, animal models, and brain imaging for CNS drug discovery - Reviews innovative therapies such as combination drugs and prodrugs for improved treatment outcomes - Analyzes challenges in targeting diseases including Alzheimer's and schizophrenia with novel therapeutic strategies - Includes real-world case studies demonstrating achievements and lessons in CNS drug development A critical reference for academic researchers and industry professionals in medicinal chemistry, pharmaceutical research, and neurobiology, Trends in CNS Drug Discovery is also an ideal resource for graduate-level courses in neuroscience or pharmaceutical sciences.…

Buch. Condition: Neu. Neuware - Trends and challenges in one of the largest areas of contemporary drug development - presented by industry professionals with a track record of discovering new drugs and treatments.

Buch. Condition: Neu. Neuware -Provides insights into the drug discovery innovations that are shaping future CNS therapiesWiley-VCH GmbH, Boschstraße 12, 69469 Weinheim 480 pp. Englisch.

Hardback. Condition: New. 1st. Provides insights into the drug discovery innovations that are shaping future CNS therapies In the vast field of neuroscience, drug discovery targeting the central nervous system (CNS) presents both extraordinary opportunities and complex challenges. Disorders such as Alzheimer's disease, schizophrenia, and epilepsy affect millions worldwide, demanding innovative therapeutic strategies. Yet understanding brain processes and overcoming the blood-brain barrier continue to pose significant hurdles for researchers and developers alike. Trends in CNS Drug Discovery offers a comprehensive overview of the methodologies, successes, and challenges shaping this critical area of pharmaceutical research. Covering a wide range of key areas, from current therapeutic paradigms to emerging technologies, this state-of-the-art volume brings together expertise from leading scientists and drug developers who address the role of cannabinoids and psychedelics in advancing CNS therapeutics, discuss emerging modalities such as protein degraders and allosteric modulators, examine funding strategies and academic-industrial collaborations, highlight advancements in brain-penetrating cancer treatments and other high-impact areas, and more. Explores cutting-edge methodologies, including biomarkers, animal models, and brain imaging for CNS drug discoveryReviews innovative therapies such as combination drugs and prodrugs for improved treatment outcomesAnalyzes challenges in targeting diseases including Alzheimer's and schizophrenia with novel therapeutic strategiesIncludes real-world case studies demonstrating achievements and lessons in CNS drug development A critical reference for academic researchers and industry professionals in medicinal chemistry, pharmaceutical research, and neurobiology, Trends in CNS Drug Discovery is also an ideal resource for graduate-level courses in neuroscience or pharmaceutical sciences.…

Hardback. Condition: New. 1st. Provides insights into the drug discovery innovations that are shaping future CNS therapies In the vast field of neuroscience, drug discovery targeting the central nervous system (CNS) presents both extraordinary opportunities and complex challenges. Disorders such as Alzheimer's disease, schizophrenia, and epilepsy affect millions worldwide, demanding innovative therapeutic strategies. Yet understanding brain processes and overcoming the blood-brain barrier continue to pose significant hurdles for researchers and developers alike. Trends in CNS Drug Discovery offers a comprehensive overview of the methodologies, successes, and challenges shaping this critical area of pharmaceutical research. Covering a wide range of key areas, from current therapeutic paradigms to emerging technologies, this state-of-the-art volume brings together expertise from leading scientists and drug developers who address the role of cannabinoids and psychedelics in advancing CNS therapeutics, discuss emerging modalities such as protein degraders and allosteric modulators, examine funding strategies and academic-industrial collaborations, highlight advancements in brain-penetrating cancer treatments and other high-impact areas, and more. Explores cutting-edge methodologies, including biomarkers, animal models, and brain imaging for CNS drug discoveryReviews innovative therapies such as combination drugs and prodrugs for improved treatment outcomesAnalyzes challenges in targeting diseases including Alzheimer's and schizophrenia with novel therapeutic strategiesIncludes real-world case studies demonstrating achievements and lessons in CNS drug development A critical reference for academic researchers and industry professionals in medicinal chemistry, pharmaceutical research, and neurobiology, Trends in CNS Drug Discovery is also an ideal resource for graduate-level courses in neuroscience or pharmaceutical sciences.…

Buch. Condition: Neu. Neuware -Provides insights into the drug discovery innovations that are shaping future CNS therapies In the vast field of neuroscience, drug discovery targeting the central nervous system (CNS) presents both extraordinary opportunities and complex challenges. Disorders such as Alzheimer's disease, schizophrenia, and epilepsy affect millions worldwide, demanding innovative therapeutic strategies. Yet understanding brain processes and overcoming the blood-brain barrier continue to pose significant hurdles for researchers and developers alike. Trends in CNS Drug Discovery offers a comprehensive overview of the methodologies, successes, and challenges shaping this critical area of pharmaceutical research. Covering a wide range of key areas, from current therapeutic paradigms to emerging technologies, this state-of-the-art volume brings together expertise from leading scientists and drug developers who address the role of cannabinoids and psychedelics in advancing CNS therapeutics, discuss emerging modalities such as protein degraders and allosteric modulators, examine funding strategies and academic-industrial collaborations, highlight advancements in brain-penetrating cancer treatments and other high-impact areas, and more. - Explores cutting-edge methodologies, including biomarkers, animal models, and brain imaging for CNS drug discovery - Reviews innovative therapies such as combination drugs and prodrugs for improved treatment outcomes - Analyzes challenges in targeting diseases including Alzheimer's and schizophrenia with novel therapeutic strategies - Includes real-world case studies demonstrating achievements and lessons in CNS drug development A critical reference for academic researchers and industry professionals in medicinal chemistry, pharmaceutical research, and neurobiology, Trends in CNS Drug Discovery is also an ideal resource for graduate-level courses in neuroscience or pharmaceutical sciences. 480 pp. Englisch.…

Hardcover. Condition: gut. 2025. Trends in CNS Drug Discovery In deutscher Sprache. pages.

Hardcover. Condition: new. Hardcover. Provides insights into the drug discovery innovations that are shaping future CNS therapies In the vast field of neuroscience, drug discovery targeting the central nervous system (CNS) presents both extraordinary opportunities and complex challenges. Disorders such as Alzheimers disease, schizophrenia, and epilepsy affect millions worldwide, demanding innovative therapeutic strategies. Yet understanding brain processes and overcoming the blood-brain barrier continue to pose significant hurdles for researchers and developers alike. Trends in CNS Drug Discovery offers a comprehensive overview of the methodologies, successes, and challenges shaping this critical area of pharmaceutical research. Covering a wide range of key areas, from current therapeutic paradigms to emerging technologies, this state-of-the-art volume brings together expertise from leading scientists and drug developers who address the role of cannabinoids and psychedelics in advancing CNS therapeutics, discuss emerging modalities such as protein degraders and allosteric modulators, examine funding strategies and academic-industrial collaborations, highlight advancements in brain-penetrating cancer treatments and other high-impact areas, and more. Explores cutting-edge methodologies, including biomarkers, animal models, and brain imaging for CNS drug discoveryReviews innovative therapies such as combination drugs and prodrugs for improved treatment outcomesAnalyzes challenges in targeting diseases including Alzheimers and schizophrenia with novel therapeutic strategiesIncludes real-world case studies demonstrating achievements and lessons in CNS drug development A critical reference for academic researchers and industry professionals in medicinal chemistry, pharmaceutical research, and neurobiology, Trends in CNS Drug Discovery is also an ideal resource for graduate-level courses in neuroscience or pharmaceutical sciences. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Hardcover. Condition: Brand New. 480 pages. 6.69x0.59x9.61 inches. In Stock. This item is printed on demand.